We updated the design of this site on September 25th. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

The Treatment Advocacy Program

This study has been completed.
Sponsor:
ClinicalTrials.gov Identifier:
NCT00164333
First Posted: September 14, 2005
Last Update Posted: September 27, 2012
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by (Responsible Party):
Centers for Disease Control and Prevention
September 9, 2005
September 14, 2005
September 27, 2012
September 2004
May 2007   (Final data collection date for primary outcome measure)
Self-reported, unprotected (without condoms) anal or vaginal sex with HIV-negative or unknown-status partners.
Same as current
Complete list of historical versions of study NCT00164333 on ClinicalTrials.gov Archive Site
Self-reported incidences of missed doses of treatment regimen.
Same as current
Not Provided
Not Provided
 
The Treatment Advocacy Program
The Treatment Advocacy Program
The purpose of the study is to test the efficacy of TAP, a behavioral intervention, in improving sexual safety and treatment adherence among gay and bisexual men infected with HIV. It is hypothesized that those who are in the intervention group will report reductions in unprotected sex with HIV-negative and unknown-status partners; and will show stricter adherence to their treatment regimens, compared to the individuals in the standard-of-care, control group.
Not Provided
Interventional
Phase 2
Allocation: Randomized
Intervention Model: Factorial Assignment
Masking: None (Open Label)
Primary Purpose: Prevention
HIV
Behavioral: TAP: Treatment Advocacy Program
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
300
April 2008
May 2007   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • HIV+ men who have sex with other men, age 18 or over, in HIV care at one of the collaborating clinics, any sexual contact within the previous six months.

Exclusion Criteria:

  • self-reported low likelihood of remaining in treatment or in the study location for 12 months, inability to comprehend the consent quiz administered during the Consent and Enrollment Visit, or unwilling to provide required locator information
Sexes Eligible for Study: Male
18 Years and older   (Adult, Senior)
Not Provided
Contact information is only displayed when the study is recruiting subjects
United States
 
 
NCT00164333
CDC-NCHSTP-3797
R 18/CCR520972-01
No
Not Provided
Not Provided
Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
Not Provided
Principal Investigator: Dogan Eroglu, PhD. Centers for Disease Control and Prevention
Centers for Disease Control and Prevention
September 2012

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP